{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:41:47Z","timestamp":1793421707773,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["1RO1 AG027910-01A1"],"award-info":[{"award-number":["1RO1 AG027910-01A1"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.neurobiolaging.2017.05.011","type":"journal-article","created":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T08:02:00Z","timestamp":1495267320000},"page":"178-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier"],"prefix":"10.1016","volume":"57","author":[{"given":"Doreen","family":"Osgood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.","family":"Messier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald D.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.39.1.361","article-title":"Biochemical, cellular, and pharmacological aspects of the multidrug transporter","volume":"39","author":"Ambudkar","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","article-title":"Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/15672050113109990002","article-title":"Neuropathological correlates of cerebral multimorbidity","volume":"10","author":"Attems","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1210\/en.2013-1472","article-title":"TGF-\u03b21 regulation of multidrug resistance P-glycoprotein in the developing male blood-brain barrier","volume":"155","author":"Baello","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncb1819","article-title":"SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells","volume":"11","author":"Bell","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00401-015-1489-x","article-title":"Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models","volume":"130","author":"Bouter","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib7","doi-asserted-by":"crossref","first-page":"690121","DOI":"10.4061\/2011\/690121","article-title":"Beta-amyloid downregulates MDR1-P-glycoprotein (Abcb1) expression at the blood-brain barrier in mice","volume":"2011","author":"Brenn","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neurobiolaging.2013.09.015","article-title":"ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy","volume":"35","author":"Carrano","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib9","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/ATVBAHA.111.225490","article-title":"Hypoxia stimulates low-density lipoprotein receptor-related protein-1 expression through hypoxia-inducible factor-1\u03b1 in human vascular smooth muscle cells","volume":"31","author":"Castellano","year":"2011","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12883-014-0169-0","article-title":"Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease","volume":"14","author":"Castello","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-9-3","article-title":"Te. Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months","volume":"9","author":"Chiu","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib12","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.neurobiolaging.2015.05.020","article-title":"P-glycoprotein expression and amyloid accumulation in human aging and AD","volume":"36","author":"Chiu","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib13","doi-asserted-by":"crossref","first-page":"e1000602","DOI":"10.1371\/journal.pgen.1000602","article-title":"Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context","volume":"5","author":"Christensen","year":"2009","journal-title":"Plos Genet."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","article-title":"Epigenetic regulation in the pathophysiology of Alzheimer's disease","volume":"90","author":"Chouliaras","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1037\/a0036433","article-title":"Amyloid-beta accumulation, neurogenesis, behavior, and the age of rats","volume":"128","author":"Church","year":"2014","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib16","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood\u2013brain barrier Increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib17","doi-asserted-by":"crossref","first-page":"e13741","DOI":"10.1371\/journal.pone.0013741","article-title":"The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells","volume":"5","author":"Daneman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","article-title":"Alzheimer neuropathologic alterations in aged cognitively normal subjects","volume":"58","author":"Davis","year":"1999","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta Neuropathol. (Ber.)"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/NEN.0000000000000046","article-title":"Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers","volume":"73","author":"Dugger","year":"2014","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jnc.12041","article-title":"1\u03b1,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells","volume":"123","author":"Durk","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2012-111400","article-title":"Co-occurrence of different pathologies in dementia: implications for dementia diagn osis","volume":"30","author":"Echavarri","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib24","doi-asserted-by":"crossref","first-page":"27576","DOI":"10.3390\/ijms161126051","article-title":"Borneol depresses P-glycoprotein function by a NF-\u03baB signaling mediated mechanism in a blood brain barrier in\u00a0vitro model","volume":"16","author":"Fan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-015-1484-2","article-title":"Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies","volume":"130","author":"Fuller","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib26","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1471-4159.1996.67020880.x","article-title":"Fate of cerebrospinal fluid-borne amyloid beta-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries","volume":"67","author":"Ghersi-Egea","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neures.2004.06.001","article-title":"Genetic and functional characteristics of the human in\u00a0vivo LRP1\/A2MR receptor suggested as a risk marker for Alzheimer's disease and other complex (degenerative) diseases","volume":"50","author":"Gl\u00e4ser","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","article-title":"Therapeutic strategies for Alzheimer's disease in clinical trials","volume":"68","author":"Gody\u0144","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","article-title":"A\u00a0hundred years of Alzheimer's disease research","volume":"52","author":"Hardy","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0896-6273(01)00234-3","article-title":"The LDL receptor gene family: (un)expected signal transducers in the brain","volume":"29","author":"Herz","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib31","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuropharm.2009.03.001","article-title":"Downregulation of LRP1 [correction of LPR1] at the blood-brain barrier in streptozotocin-induced diabetic mice","volume":"56","author":"Hong","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2009-1074","article-title":"Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition","volume":"17","author":"Jaeger","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuron.2009.11.013","article-title":"Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance","volume":"64","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0167-4781(89)90107-3","article-title":"Structure of the low-density lipoprotein receptor-related protein (LRP) promoter","volume":"1009","author":"K\u00fctt","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"beta-Amyloid efflux mediated by P-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib38","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.1074\/jbc.272.26.16498","article-title":"Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end-products","volume":"272","author":"Li","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/syn.20644","article-title":"Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice","volume":"63","author":"Liu","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1","volume":"56","author":"Liu","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib41","first-page":"903","article-title":"Sevoflurane alters the expression of receptors and enzymes involved in A\u03b2 clearance in rats. Acta Anaesthesiol","volume":"57","author":"Liu","year":"2013","journal-title":"Scand"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nature02661","article-title":"Gene regulation and DNA damage in the ageing human brain","volume":"429","author":"Lu","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","article-title":"Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions","volume":"38","author":"Mackic","year":"2002","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0005-2736(85)90179-8","article-title":"Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon","volume":"819","author":"Mann","year":"1985","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","article-title":"Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease","volume":"1230","author":"Miller","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib46","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.leukres.2014.06.001","article-title":"Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line","volume":"38","author":"Moreira","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib47","series-title":"Alzheimer's Disease Unraveling the Mystery","author":"National Institute of Aging","year":"2002"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood-CSF barrier is age dependent","volume":"8","author":"Pascale","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib49","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-4159.2006.04295.x","article-title":"Regulation of P-glycoprotein function by sphingosine kinase-1 in brain endothelial cells","volume":"100","author":"Pilorget","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/alzrt220","article-title":"Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future","volume":"5","author":"Prins","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Eng. J. Med."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-60761-744-0_18","article-title":"Epigenetic changes in the brain: measuring global histone modifications","volume":"670","author":"Rumbaugh","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib53","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib54","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1073\/pnas.91.19.8807","article-title":"Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins","volume":"91","author":"Schmidt","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib55","first-page":"D1151","article-title":"Receptor for age (RAGE) is a gene within the major histocompatibility class lll region: implications for host response mechanisms in homeostasis and chronic disease","volume":"6","author":"Schmidt","year":"2001","journal-title":"Front. Biosci."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib56","series-title":"Hormones and Signaling","first-page":"41","article-title":"RAGE: a receptor with a taste for multiple ligands and varied pathophysiologic states","author":"Schmidt","year":"1998"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"924","author":"Selkoe","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib58","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-\u03b21\u201340 peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib59","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","article-title":"The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type","volume":"57","author":"Silverberg","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib60","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3171\/jns.2002.97.6.1271","article-title":"Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus","volume":"97","author":"Silverberg","year":"2002","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib61","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1474-4422(03)00487-3","article-title":"Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis","volume":"2","author":"Silverberg","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/NEN.0b013e3181c8ad2f","article-title":"Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib63","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/NEN.0b013e3181f46e25","article-title":"Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging","volume":"69","author":"Silverberg","year":"2010","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0169-328X(98)00351-9","article-title":"Decrease with age in methylcytosines in the promoter region of receptor for advanced glycation end products (RAGE) gene in autopsy human cortex","volume":"65","author":"Tohgi","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/17512433.2015.1034690","article-title":"What lessons can be learned from failed Alzheimer's disease trials?","volume":"8","author":"Toyn","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib66","doi-asserted-by":"crossref","first-page":"B492","DOI":"10.1093\/gerona\/54.11.B492","article-title":"Growth curves and survival characteristics of the animals used in the biomarkers of aging program","volume":"54","author":"Turturro","year":"1999","journal-title":"J.\u00a0Gerontol. A. Biol.Sci.Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib67","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.91.11.4766","article-title":"Advanced glycation end products contribute to\u00a0amyloidosis in Alzheimer's disease","volume":"91","author":"Vitek","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","article-title":"Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans","volume":"12","author":"Vogelgesang","year":"2002","journal-title":"Pharmacogen"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11357-011-9375-5","article-title":"Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease","volume":"35","author":"Walker","year":"2013","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib70","doi-asserted-by":"crossref","first-page":"34554","DOI":"10.1074\/jbc.M801487200","article-title":"The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in\u00a0vitro model of the blood-brain barrier cells","volume":"283","author":"Yamada","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib71","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00401-008-0435-6","article-title":"Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia","volume":"116","author":"Yan","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.pathmechdis.2.010506.092044","article-title":"The aging brain","volume":"3","author":"Yankner","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.089","article-title":"Expression of drug transporters at the blood\u2013brain barrier using an optimized isolated rat brain microvessel strategy","volume":"1134","author":"Yousif","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib74","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/jnc.12944","article-title":"Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-\u03baB","volume":"131","author":"Zhang","year":"2014","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib75","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nn.4025","article-title":"Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance","volume":"18","author":"Zhao","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib76","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1023\/A:1016254514167","article-title":"Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier","volume":"12","author":"Zlokovic","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib77","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood-brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(85)90423-8","article-title":"Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine)","volume":"336","author":"Zlokovic","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib79","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid \u03b2-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2017.05.011_bib80","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.1987.tb03431.x","article-title":"Transport of leucine-enkephalin across the blood-brain barrier in the perfused Guinea pig brain","volume":"49","author":"Zlokovi\u0107","year":"1987","journal-title":"J.\u00a0Neurochem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017301665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458017301665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:14:23Z","timestamp":1719213263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458017301665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":80,"alternative-id":["S0197458017301665"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.05.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}